Myositis specific antibodies: frequency in different populations

Area of Science:

• Rheumatology
• Immunology
• Neurology

Background:

• Myositis specific autoantibodies (MSA) are highly specific diagnostic markers for idiopathic inflammatory myopathies (IIM).
• Existing research indicates MSA are not found in other neuromuscular or connective tissue diseases.
• Geographical variations in MSA prevalence within IIM populations require further investigation.

Purpose of the Study:

• To compare the frequency of MSA in IIM patients from Poland and North America.
• To investigate the prevalence of the immunological marker PM-Sci in scleromyositis patients across different geographic cohorts.
• To reinforce the association between specific MSAs and distinct clinical syndromes within IIM.

Main Methods:

• Comparative analysis of MSA frequency in two distinct IIM patient cohorts (Poland and North America).
• Statistical evaluation of the occurrence of the PM-Sci marker in scleromyositis patients from both groups.
• Review of established associations between MSAs and specific IIM clinical presentations.

Main Results:

• No significant statistical difference was found in the overall frequency of MSA between Polish (21%) and North American (25%) IIM patients.
• A significantly higher prevalence of the PM-Sci marker was observed in Polish scleromyositis patients (22.85%) compared to North American patients (7.1%).
• The prevalence of PM-Sci in the Polish cohort exceeded previously reported figures for North American and Japanese populations.

Conclusions:

• MSA frequency is comparable between Polish and North American IIM patients.
• The elevated occurrence of PM-Sci in Polish scleromyositis patients suggests potential geographical variations.
• These findings support the routine inclusion of MSA testing in the diagnostic workup of IIM.